Multiple Myeloma Clinical Trial

Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma

Summary

This study will evaluate the efficacy and safety of belantamab mafodotin in combination with pomalidomide and dexamethasone (Arm A) compared with that of combination of pomalidomide, bortezomib and dexamethasone (Arm B) in participants with relapsed/refractory multiple myeloma (RRMM).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Capable of giving signed informed consent.
Male or female, 18 years or older.
Have a confirmed diagnosis of multiple myeloma (MM) as defined by the International Myeloma Working Group (IMWG) criteria.
Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2.
Have been previously treated with at least 1 prior line of MM therapy including a lenalidomide-containing regimen and must have documented disease progression during or after their most recent therapy.

Must have at least 1 aspect of measurable disease defined as one of the following;

Urine M-protein excretion greater than or equal to (≥)200 milligrams (mg) per 24-hour, or
Serum M-protein concentration ≥0.5 grams/deciliters (g/dL) (≥5.0 g/liter [L]), or
Serum free light chain (FLC) assay: involved FLC level ≥10 mg/dL (≥100 mg/L) and an abnormal serum free light chain ratio (less than [<]0.26 or greater than [>]1.65) only if participant has no measurable urine or serum M spike.
Have undergone autologous stem cell transplant (ASCT) or are considered transplant ineligible. Participants with a history of ASCT are eligible for study participation provided the following eligibility criteria are met: a. ASCT was >100 days prior to the first dose of study medication. b. No active bacterial, viral, or fungal infection(s) present
All prior treatment-related toxicities (defined by National Cancer Institute Common Terminology Criteria for Adverse Events [NCI-CTCAE] version 5.0) must be less than or equal to (≤)Grade 1 at the time of enrolment, except for alopecia.
Adequate organ system functions as mentioned in the protocol.
Male and female participants agree to abide by protocol-defined contraceptive requirements.

Exclusion Criteria:

Active plasma cell leukemia, symptomatic amyloidosis or active polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma proliferative disorder, and skin changes (POEMS) syndrome at the time of screening.
Prior allogeneic SCT.
Systemic anti-myeloma therapy (including chemotherapy and systemic steroids) within 14 days or five half-lives (whichever is shorter) preceding the first dose of study drug; prior treatment with a monoclonal antibody drug within 30 days of receiving the first dose of study drugs.
Plasmapheresis within 7 days prior to the first dose of study drug.
Received prior treatment with or intolerant to pomalidomide.
Received prior Beta cell maturation antigen (BCMA) targeted therapy.
Intolerant to bortezomib or refractory to bortezomib (for example; participant experienced progressive disease during treatment, or within 60 days of completing treatment, with a bortezomib-containing regimen of 1.3 mg/meter square [m^2] twice weekly).

Evidence of cardiovascular risk including any of the following;

Evidence of current clinically significant untreated arrhythmias, including clinically significant electrocardiogram abnormalities including second degree (Mobitz type II) or third degree atrioventricular (AV) block.
Recent history within (3 months of screening) of myocardial infarction, acute coronary syndromes (including unstable angina), coronary angioplasty, or stenting or bypass grafting .
Class III or IV heart failure as defined by the New York Heart Association (NYHA) functional classification system
Uncontrolled hypertension.
Any major surgery within the last 4 weeks.

Previous or concurrent invasive malignancy other than multiple myeloma, except:

The disease must be considered medically stable for at least 2 years; or
The participant must not be receiving active therapy, other than hormonal therapy for this disease.
Known immediate or delayed hypersensitivity reaction or idiosyncratic reaction to belantamab mafodotin or drugs chemically related to belantamab mafodotin, or any of the components of the study treatment.
Evidence of active mucosal or internal bleeding.
Cirrhosis or current unstable liver or biliary disease per investigator assessment defined by the presence of ascites, encephalopathy, coagulopathy, hypoalbuminemia, esophageal or gastric varices, persistent jaundice.
Active infection requiring treatment.
Known or active human immunodeficiency virus (HIV) infection, hepatitis B or hepatitis C will be excluded unless the protocol-defined criteria are met.
Presence of active renal conditions (such as infection, severe renal impairment requiring dialysis or any other condition that could affect participant's safety).
Ongoing Grade 2 peripheral neuropathy with pain within 14 days prior to randomization or ≥Grade 3 peripheral neuropathy.
Active or history of venous and arterial thromboembolism within the past 3 months.
Contraindications to or unwilling to undergo protocol-required anti-thrombotic prophylaxis.
Current corneal disease except for mild punctate keratopathy.
Any serious and/or unstable pre-existing medical, psychiatric disorder or other conditions (including laboratory abnormalities) that could interfere with participant's safety, obtaining informed consent or compliance to the study procedures.
Pregnant or lactating female.

Study is for people with:

Multiple Myeloma

Phase:

Phase 3

Estimated Enrollment:

300

Study ID:

NCT04484623

Recruitment Status:

Recruiting

Sponsor:

GlaxoSmithKline

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 167 Locations for this study

See Locations Near You

GSK Investigational Site
Tucson Arizona, 85712, United States More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Manuel R Modiano
Principal Investigator
GSK Investigational Site
Denver Colorado, 80218, United States More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Henning Schade
Principal Investigator
GSK Investigational Site
Fort Myers Florida, 33901, United States More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Syed Farhan Zafar
Principal Investigator
GSK Investigational Site
New Port Richey Florida, 34655, United States More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Gustaro A Fonseca
Principal Investigator
GSK Investigational Site
Pembroke Pines Florida, 33024, United States More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Isaac Levy
Principal Investigator
GSK Investigational Site
Coeur d'Alene Idaho, 83814, United States More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Danko Martincic
Principal Investigator
GSK Investigational Site
Boston Massachusetts, 02215, United States More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Clifton Mo
Principal Investigator
GSK Investigational Site
Kansas City Missouri, 64132, United States More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Suman Kambhampati
Principal Investigator
GSK Investigational Site
Pittsburgh Pennsylvania, 15224, United States More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Santhosh Sadashiv
Principal Investigator
GSK Investigational Site
Nashville Tennessee, 37203, United States More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Jesus G Berdeja
Principal Investigator
GSK Investigational Site
Seattle Washington, 98109, United States More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Edward Libby
Principal Investigator
GSK Investigational Site
Spokane Washington, 99202, United States More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Brett Gourley
Principal Investigator
GSK Investigational Site
Milwaukee Wisconsin, 53226, United States More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Binod Dhakal
Principal Investigator
GSK Investigational Site
Canberra Australian Capital Territory, 2605, Australia More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Edwin Lee
Principal Investigator
GSK Investigational Site
Darlinghurst New South Wales, 2010, Australia More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Keith Fay
Principal Investigator
GSK Investigational Site
Gosford New South Wales, 2250, Australia More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Cecily Forsyth
Principal Investigator
GSK Investigational Site
Port Macquarie New South Wales, 2444, Australia More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Jock Simpson
Principal Investigator
GSK Investigational Site
Randwick New South Wales, 2031, Australia More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Mark Hertzberg
Principal Investigator
GSK Investigational Site
Wollongong New South Wales, 2500, Australia More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Peter Presgrave
Principal Investigator
GSK Investigational Site
Benowa Queensland, 4217, Australia More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Hanlon Sia
Principal Investigator
GSK Investigational Site
South Brisbane Queensland, 4101, Australia More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Ian Irving
Principal Investigator
GSK Investigational Site
Adelaide South Australia, 5000, Australia More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Huey-Shin Cindy Lee
Principal Investigator
GSK Investigational Site
Fitzroy Victoria, 3065, Australia More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Hang Quach
Principal Investigator
GSK Investigational Site
Geelong Victoria, 3220, Australia More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Philip Campbell
Principal Investigator
GSK Investigational Site
Heidelberg Victoria, 3084, Australia More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Andrew Lim
Principal Investigator
GSK Investigational Site
Malvern Victoria, 3144, Australia More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Melita Kenealy
Principal Investigator
GSK Investigational Site
Nedlands Western Australia, 6009, Australia More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Bradley Augustson
Principal Investigator
GSK Investigational Site
Porto Alegre Rio Grande Do Sul, 90035, Brazil More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Laura Maria Fogliatto
Principal Investigator
GSK Investigational Site
Porto Alegre Rio Grande Do Sul, 90470, Brazil More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Marcelo Capra
Principal Investigator
GSK Investigational Site
Joinville Santa Catarina, 89201, Brazil More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Marcelo Pitombeira de Lacerda
Principal Investigator
GSK Investigational Site
Curitiba , 80530, Brazil More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Francisco Cordeiro
Principal Investigator
GSK Investigational Site
Rio de Janeiro , 22793, Brazil More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Angelo Maiolino
Principal Investigator
GSK Investigational Site
São Paulo , 01509, Brazil More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Jayr Schmidt Filho
Principal Investigator
GSK Investigational Site
São Paulo , 04537, Brazil More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Vania Hungria
Principal Investigator
GSK Investigational Site
Ottawa Ontario, K1H 8, Canada More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Arleigh McCurdy
Principal Investigator
GSK Investigational Site
Toronto Ontario, M5G 2, Canada More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Suzanne Trudel
Principal Investigator
GSK Investigational Site
Montreal , H2X 0, Canada More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Emilie Lemieux-Blanchard
Principal Investigator
GSK Investigational Site
Guangzhou Guangdong, 51006, China More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Zhongjun Xia
Principal Investigator
GSK Investigational Site
Shenzhen Guangdong, 51802, China More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Xin Du
Principal Investigator
GSK Investigational Site
Wuhan Hubei, 43002, China More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Chunyan Sun
Principal Investigator
GSK Investigational Site
Changsha Hunan, 41001, China More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Xin Li
Principal Investigator
GSK Investigational Site
Nanchang Jiangxi, 33000, China More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Fei Li
Principal Investigator
GSK Investigational Site
Shenyang Liaoning, 11000, China More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Wei Yang
Principal Investigator
GSK Investigational Site
Tianjin , 30002, China More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Weiwei Sui
Principal Investigator
GSK Investigational Site
Brno , 625 0, Czechia More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Ludek Pour
Principal Investigator
GSK Investigational Site
Hradec Kralove , 500 0, Czechia More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Jakub Radocha
Principal Investigator
GSK Investigational Site
Praha 2 , 128 0, Czechia More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Ivan Spicka
Principal Investigator
GSK Investigational Site
Dijon cedex , 21079, France More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Denis Caillot
Principal Investigator
GSK Investigational Site
Marseille Cedex 9 , 13273, France More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Anne-Marie Stoppa
Principal Investigator
GSK Investigational Site
Périgueux cedex , 24019, France More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Claire Calmettes
Principal Investigator
GSK Investigational Site
Toulouse cedex 9 , 31059, France More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Aurore Perrot
Principal Investigator
GSK Investigational Site
Vandeouvre-les-Nancy , 54500, France More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Pierre Feugier
Principal Investigator
GSK Investigational Site
Heidelberg Baden-Wuerttemberg, 69120, Germany More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Marc Raab
Principal Investigator
GSK Investigational Site
Tuebingen Baden-Wuerttemberg, 72076, Germany More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Britta Besemer
Principal Investigator
GSK Investigational Site
Wuerzburg Bayern, 97080, Germany More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Martin Kortuem
Principal Investigator
GSK Investigational Site
Mainz Rheinland-Pfalz, 55101, Germany More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Markus Munder
Principal Investigator
GSK Investigational Site
Leipzig Sachsen, 04103, Germany More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Song-Yau Wang
Principal Investigator
GSK Investigational Site
Jena Thueringen, 07747, Germany More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Marie von Lilienfeld-Toal
Principal Investigator
GSK Investigational Site
Berlin , 12351, Germany More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Maike de Wit
Principal Investigator
GSK Investigational Site
Hamburg , 20246, Germany More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Katja Weisel
Principal Investigator
GSK Investigational Site
Athens , 10676, Greece More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Sosana Delimpasi
Principal Investigator
GSK Investigational Site
Athens , 115 2, Greece More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Meletios Athanasios Dimopoulos
Principal Investigator
GSK Investigational Site
Athens , 11525, Greece More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Konstantinos Anargyrou
Principal Investigator
GSK Investigational Site
Athens , 11527, Greece More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Athanasios Galanopoulos
Principal Investigator
GSK Investigational Site
Ioannina , 45 50, Greece More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Eleftheria Hatzimichael
Principal Investigator
GSK Investigational Site
Larisa , 41110, Greece More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
George Vassilopoulos
Principal Investigator
GSK Investigational Site
Rio/Patras , 26504, Greece More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Argiris S. Symeonidis
Principal Investigator
GSK Investigational Site
Thessaloniki , 546 3, Greece More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Evdoxia Hatjiharissi
Principal Investigator
GSK Investigational Site
Thessaloniki , 57010, Greece More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Michail Iskas
Principal Investigator
GSK Investigational Site
Ashdod , 77476, Israel More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Merav Leiba
Principal Investigator
GSK Investigational Site
Beer-Sheva , 84101, Israel More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Ory Rouvio
Principal Investigator
GSK Investigational Site
Haifa , 31096, Israel More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Inna Tsoran-Rosenthal
Principal Investigator
GSK Investigational Site
Jerusalem , 91031, Israel More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Aharon Ronson
Principal Investigator
GSK Investigational Site
Jerusalem , 91120, Israel More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Moshe Etzion Gatt
Principal Investigator
GSK Investigational Site
Kfar Saba , 44281, Israel More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Osnat Jarchowsky Dolberg
Principal Investigator
GSK Investigational Site
Nahariya , 22100, Israel More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Celia Suriu
Principal Investigator
GSK Investigational Site
Petach Tikva , 49100, Israel More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Amos M Cohen
Principal Investigator
GSK Investigational Site
Ramat Gan , 52621, Israel More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Hila Magen
Principal Investigator
GSK Investigational Site
Tel Aviv , 64239, Israel More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Irit Avivi
Principal Investigator
GSK Investigational Site
Bologna Emilia-Romagna, 40138, Italy More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Michele Cavo
Principal Investigator
GSK Investigational Site
Roma Lazio, 00161, Italy More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Maurizio Martelli
Principal Investigator
GSK Investigational Site
Pavia Lombardia, 27100, Italy More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Silvia Mangiacavalli
Principal Investigator
GSK Investigational Site
San Giovanni Rotondo Puglia, 71013, Italy More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Nicola Cascavilla
Principal Investigator
GSK Investigational Site
Milano , 20122, Italy More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Luca Baldini
Principal Investigator
GSK Investigational Site
Aichi , 467-8, Japan More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Shinsuke Iida
Principal Investigator
GSK Investigational Site
Chiba , 296-8, Japan More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Kosei Matsue
Principal Investigator
GSK Investigational Site
Ehime , 790-8, Japan More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Tomoaki Fujisaki
Principal Investigator
GSK Investigational Site
Fukuoka , 810-8, Japan More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Hiromi Iwasaki
Principal Investigator
GSK Investigational Site
Fukushima , 960-1, Japan More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Takayuki Ikezoe
Principal Investigator
GSK Investigational Site
Gunma , 371-8, Japan More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Hiroshi Handa
Principal Investigator
GSK Investigational Site
Gunma , 377-0, Japan More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Morio Matsumoto
Principal Investigator
GSK Investigational Site
Hiroshima , 720-0, Japan More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Taiga Kuroi
Principal Investigator
GSK Investigational Site
Hokkaido , 060-8, Japan More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Hideki Goto
Principal Investigator
GSK Investigational Site
Iwate , 028-3, Japan More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Shigeki Ito
Principal Investigator
GSK Investigational Site
Kumamoto , 860-0, Japan More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Toshiro Kawakita
Principal Investigator
GSK Investigational Site
Kyoto , 602-8, Japan More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Junya Kuroda
Principal Investigator
GSK Investigational Site
Okayama , 701-1, Japan More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Kazutaka Sunami
Principal Investigator
GSK Investigational Site
Osaka , 565-0, Japan More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Michiko Ichii
Principal Investigator
GSK Investigational Site
Saitama , 350-0, Japan More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Yasuhito Terui
Principal Investigator
GSK Investigational Site
Tokushima , 770-8, Japan More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
GSKClinicalSuppor[email protected]
Shuji Ozaki
Principal Investigator
GSK Investigational Site
Tokyo , 108-8, Japan More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Yoichi Imai
Principal Investigator
GSK Investigational Site
Tokyo , 135-8, Japan More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Kazuhito Suzuki
Principal Investigator
GSK Investigational Site
Tottori , 683-8, Japan More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Tetsuya Fukuda
Principal Investigator
GSK Investigational Site
Yamagata , 990-9, Japan More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Kenichi Ishizawa
Principal Investigator
GSK Investigational Site
Busan , 49241, Korea, Republic of More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Ho-Jin Shin
Principal Investigator
GSK Investigational Site
Gyeonggi-do , 10408, Korea, Republic of More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
HyeonSeok Eom
Principal Investigator
GSK Investigational Site
Hwasun-gun, Jeollanam-do , 58128, Korea, Republic of More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Je-Jung Lee
Principal Investigator
GSK Investigational Site
Incheon , 405-7, Korea, Republic of More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Jae Hoon Lee
Principal Investigator
GSK Investigational Site
Seoul , 03722, Korea, Republic of More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Jin Seok Kim
Principal Investigator
GSK Investigational Site
Seoul , 06351, Korea, Republic of More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Kihyun Kim
Principal Investigator
GSK Investigational Site
Seoul , 06591, Korea, Republic of More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Chang Ki Min
Principal Investigator
GSK Investigational Site
Seoul , 110-7, Korea, Republic of More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
JaMin Byun
Principal Investigator
GSK Investigational Site
Ulsan , 44033, Korea, Republic of More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Jae-Cheol Jo
Principal Investigator
GSK Investigational Site
Auckland , 2025, New Zealand More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Sharon Jackson
Principal Investigator
GSK Investigational Site
Auckland , 622, New Zealand More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Merit Hanna
Principal Investigator
GSK Investigational Site
Christchurch , 8011, New Zealand More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Peter Ganly
Principal Investigator
GSK Investigational Site
Dunedin , 9001, New Zealand More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Kathryn Forwood
Principal Investigator
GSK Investigational Site
Grafton, Auckland , 1023, New Zealand More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Nicole Yu-Shan Chien
Principal Investigator
GSK Investigational Site
Hamilton , 2001, New Zealand More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Hugh Goodman
Principal Investigator
GSK Investigational Site
Tauranga , 3143, New Zealand More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Gillian Corbett
Principal Investigator
GSK Investigational Site
Bydgoszcz , 85-16, Poland More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Jaroslaw Czyz
Principal Investigator
GSK Investigational Site
Gdansk , 80-21, Poland More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Magdalena Dutka
Principal Investigator
GSK Investigational Site
Krakow , 31-50, Poland More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Artur Jurczyszyn
Principal Investigator
GSK Investigational Site
Lodz , 93-51, Poland More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Tadeusz Robak
Principal Investigator
GSK Investigational Site
Lublin , 20-09, Poland More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Krzysztof Giannopoulos
Principal Investigator
GSK Investigational Site
Wroclaw , 50-36, Poland More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
GSKClinicalSupport[email protected]
Tomasz Wrobel
Principal Investigator
GSK Investigational Site
Kaluga , 24800, Russian Federation More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Elena Borisenkova
Principal Investigator
GSK Investigational Site
Moscow , 12528, Russian Federation More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Vladimir Ivanovich Vorobiev
Principal Investigator
GSK Investigational Site
Moscow , 12528, Russian Federation More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Sergey Semochkin
Principal Investigator
GSK Investigational Site
Nizhniy Novgorod , 60312, Russian Federation More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Olga Samoilova
Principal Investigator
GSK Investigational Site
Novosibirsk , 63008, Russian Federation More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Yulia Dyachkova
Principal Investigator
GSK Investigational Site
Omsk , 64401, Russian Federation More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Mikhail Dvorkin
Principal Investigator
GSK Investigational Site
Saint Petersburg , 19734, Russian Federation More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Yuriy Osipov
Principal Investigator
GSK Investigational Site
Samara , 44309, Russian Federation More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Igor Davydkin
Principal Investigator
GSK Investigational Site
Sochi , 35405, Russian Federation More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Dmitriy Kirtbaya
Principal Investigator
GSK Investigational Site
St'Petersburg , 19102, Russian Federation More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Sergey Voloshin
Principal Investigator
GSK Investigational Site
St. Petersburg , 197 0, Russian Federation More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Olga S. Uspenskaya
Principal Investigator
GSK Investigational Site
Tula , 30005, Russian Federation More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Elena Volodicheva
Principal Investigator
GSK Investigational Site
Móstoles Madrid, 28933, Spain More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Alberto Velasco Valdazo
Principal Investigator
GSK Investigational Site
Madrid Navarra, 28027, Spain More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Jesús San Miguel Izquierdo
Principal Investigator
GSK Investigational Site
Badalona , 08036, Spain More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Laura Rosinol Dachs
Principal Investigator
GSK Investigational Site
Barcelona , 8035, Spain More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Mercedes Gironella Mesa
Principal Investigator
GSK Investigational Site
Gijon , 33204, Spain More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Esther González García
Principal Investigator
GSK Investigational Site
Hospitalet de Llobregat (Barcelona) , 08908, Spain More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Ana Maria Sureda Balarí
Principal Investigator
GSK Investigational Site
Madrid , 28006, Spain More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Adrián Alegre Amor
Principal Investigator
GSK Investigational Site
Murcia , 30008, Spain More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Felipe De Arriba de la Fuente
Principal Investigator
GSK Investigational Site
Palma de Mallorca , 07010, Spain More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Antonia Sampol Mayol
Principal Investigator
GSK Investigational Site
Pamplona , 31008, Spain More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Jesús San Miguel Izquierdo
Principal Investigator
GSK Investigational Site
Pozuelo De Alarcón/Madrid , 28223, Spain More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
María del Carmen Martínez Chamorro
Principal Investigator
GSK Investigational Site
Salamanca , 37007, Spain More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
María Victoria Mateos Manteca
Principal Investigator
GSK Investigational Site
Sevilla , 41013, Spain More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Estrella Carrillo Cruz
Principal Investigator
GSK Investigational Site
Valencia , 46026, Spain More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Javier de la Rubia Comos
Principal Investigator
GSK Investigational Site
Ankara , 06100, Turkey More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Mehmet Sinan Dal
Principal Investigator
GSK Investigational Site
Ankara , 06560, Turkey More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Zubeyde Ozkurt
Principal Investigator
GSK Investigational Site
Ankara , 6110, Turkey More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Meral Beksac
Principal Investigator
GSK Investigational Site
Istanbul , 34214, Turkey More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Omur G Sevindik
Principal Investigator
GSK Investigational Site
Izmir , 35100, Turkey More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Guray Saydam
Principal Investigator
GSK Investigational Site
Izmir , 35340, Turkey More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Hayri Ozsan
Principal Investigator
GSK Investigational Site
Kocaeli , 41400, Turkey More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Zafer Gulbas
Principal Investigator
GSK Investigational Site
Mersin , 33343, Turkey More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Anil Tombak
Principal Investigator
GSK Investigational Site
Samsun , 55139, Turkey More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Mehmet Turgut
Principal Investigator
GSK Investigational Site
Southampton Hampshire, SO16 , United Kingdom More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Matthew Jenner
Principal Investigator
GSK Investigational Site
Airdrie Lanarkshire, ML6 0, United Kingdom More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Iain Singer
Principal Investigator
GSK Investigational Site
Stoke-on-Trent Staffordshire, ST4 6, United Kingdom More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Kamaraj Karunanithi
Principal Investigator
GSK Investigational Site
Sutton Surrey, SM2 5, United Kingdom More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Kevin Boyd
Principal Investigator
GSK Investigational Site
Bournemouth , BH7 7, United Kingdom More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Rachel Hall
Principal Investigator
GSK Investigational Site
London , W12 0, United Kingdom More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Aristeidis Chaidos
Principal Investigator
GSK Investigational Site
Plymouth , PL6 8, United Kingdom More Info
US GSK Clinical Trials Call Center
Contact
877-379-3718
[email protected]
EU GSK Clinical Trials Call Centre
Contact
+44 (0) 20 8990 4466
[email protected]
Hannah Mary Hunter
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Multiple Myeloma

Phase:

Phase 3

Estimated Enrollment:

300

Study ID:

NCT04484623

Recruitment Status:

Recruiting

Sponsor:


GlaxoSmithKline

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.